PureTech Health (PRTC) Enterprise Value (2019 - 2025)
PureTech Health (PRTC) reported Enterprise Value of -$277.3 million for Q4 2025, up 38.92% year-over-year from -$199.6 million in Q4 2024, and up 13.32% on a QoQ basis from -$319.9 million in Q2 2025.
PureTech Health (PRTC) has 6 years of Enterprise Value data on file, last reported at -$277.3 million in Q4 2025.
- Quarterly Enterprise Value rose 38.92% year-over-year to -$277.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$277.3 million (up 38.92% YoY) and the FY2025 annual result came in at -$277.3 million, up 38.92% from the prior year.
- Enterprise Value rose to -$277.3 million in Q4 2025 per PRTC's latest filing, from -$319.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$277.3 million in Q4 2025 and bottomed at -$465.7 million in Q4 2021.
- The 4-year median for Enterprise Value is -$350.1 million (2022), against an average of -$373.4 million.
- The widest annual swing landed in 2021, when Enterprise Value fell 15.31%; it then soared 38.92% in 2025.
- Tracing PRTC's Enterprise Value over 4 years: stood at -$465.7 million in 2021, then gained by 24.83% to -$350.1 million in 2022, then decreased by 29.68% to -$454.0 million in 2024, then soared by 38.92% to -$277.3 million in 2025.
- Per Business Quant, the three latest PRTC Enterprise Value figures stand at -$277.3 million (Q4 2025), -$319.9 million (Q2 2025), and -$454.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -3.01 Bn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | -277.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -277.30 Mn |
| Jun 30, 2025 | -319.91 Mn |
| Dec 31, 2024 | -453.97 Mn |
| Dec 31, 2022 | -350.07 Mn |
| Dec 31, 2021 | -465.71 Mn |
| Dec 31, 2020 | -403.88 Mn |
| Dec 31, 2019 | -162.45 Mn |